Aron M. Knickerbocker

2018

In 2018, Aron M. Knickerbocker earned a total compensation of $2.1M as President and Chief Executive Officer at Five Prime Therapeutics, a 71% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$225,000
Option Awards$1,073,484
Salary$500,000
Stock Awards$280,350
Other$6,072
Total$2,084,906

Knickerbocker received $1.1M in option awards, accounting for 51% of the total pay in 2018.

Knickerbocker also received $225K in non-equity incentive plan, $500K in salary, $280.4K in stock awards and $6.1K in other compensation.

Rankings

In 2018, Aron M. Knickerbocker's compensation ranked 5,512th out of 14,244 executives tracked by ExecPay. In other words, Knickerbocker earned more than 61.3% of executives.

ClassificationRankingPercentile
All
5,512
out of 14,244
61st
Division
Manufacturing
2,077
out of 5,758
64th
Major group
Chemicals And Allied Products
766
out of 2,119
64th
Industry group
Drugs
641
out of 1,808
65th
Industry
Pharmaceutical Preparations
494
out of 1,382
64th

Pay ratio

Aron M. Knickerbocker's Pay$2,084,906
Median Employee's Pay$201,670
Pay Ratio

10

to 1

In 2018, the annual total compensation of Aron M. Knickerbocker was $2,084,906.

The annual total compensation of the median employee at Five Prime Therapeutics was $201,670.

The ratio of Aron M. Knickerbocker's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 29, 2019.

Knickerbocker's colleagues

We found six more compensation records of executives who worked with Aron M. Knickerbocker at Five Prime Therapeutics in 2018.

2018

David Smith

Five Prime Therapeutics

Chief Financial Officer

2018

Bryan Irving

Five Prime Therapeutics

Chief Scientific Officer

2018

Helen Collins

Five Prime Therapeutics

Chief Medical Officer

2018

Francis Sarena

Five Prime Therapeutics

Secretary

2018

Linda Rubinstein

Five Prime Therapeutics

Chief Financial Officer

2018

Marc Belsky

Five Prime Therapeutics

Chief Financial Officer

News

In-depth

You may also like